Publicaties
Gekozen filters:
Gekozen filters:
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance Instituut voor Tropische Geneeskunde
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis Instituut voor Tropische Geneeskunde
The First Global Forum on Bacterial Infections calls for urgent action to contain antibiotic resistance Instituut voor Tropische Geneeskunde
Does HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia? Instituut voor Tropische Geneeskunde
OBJECTIVE: The microbiologic causes of bloodstream infections (BSI) may differ between HIV-positive and HIV-negative patients and direct initial empiric antibiotic treatment (i.e. treatment before culture results are available). We retrospectively assessed community-acquired BSI episodes in adults in Cambodia according to HIV status for spectrum of bacterial pathogens, antibiotic resistance patterns and appropriateness of empiric antibiotics. ...
Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin Instituut voor Tropische Geneeskunde
Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries Instituut voor Tropische Geneeskunde
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda Instituut voor Tropische Geneeskunde Universiteit Antwerpen
Evaluation of the Genotype(R) MTBDRplus assay as a tool for drug resistance surveys Instituut voor Tropische Geneeskunde
SETTING: A national tuberculosis (TB) drug resistance survey in Tanzania. OBJECTIVE: To compare the performance of the Genotype(R) MTBDRplus line-probe assay (LPA) on smear-positive sputum specimens with conventional culture and isoniazid (INH) plus rifampicin (RMP) drug susceptibility testing (DST). DESIGN: Mycobacterium tuberculosis isolates tested at the Tanzanian Central TB Reference Laboratory (CTRL) were submitted for quality assurance of ...